Matrix metalloproteinase-13 is required for zebra fish (Danio rerio) development and is a target for glucocorticoids.

Matrix metalloproteinases (MMPs) are endopeptidases that degrade the proteins of the extracellular matrix (ECM). Expression and activity of the MMPs are essential for embryogenesis, where MMPs participate in the normal ECM remodeling that occurs during tissue morphogenesis and development. Studies have demonstrated that MMP gene expression is inhibited by glucocorticoids in mammalian cell culture systems and that exposure to glucocorticoids causes developmental abnormalities in several species. Therefore, we proposed that glucocorticoids impede normal development through alteration of MMP expression. Zebra fish (Danio rerio) were used as a model to study MMP-13 expression both during normal embryogenesis and following acute exposure to two glucocorticoids, dexamethasone, and hydrocortisone. MMP-13 is one of three collagenases identified in vertebrates that catalyzes the degradation of type I collagens at neutral pH. MMP-13 expression varied during zebra fish development, with peak expression at 48 h post-fertilization (hpf). Morpholino knockdown studies showed that MMP-13 expression is necessary for normal zebra fish embryogenesis. Acute exposure to dexamethasone and hydrocortisone resulted in abnormal zebra fish development including craniofacial abnormalities, altered somitogenesis, blood pooling and pericardial and yolk sac edema as well as increased MMP-13 mRNA and activity at 72 hpf. In situ hybridization experiments were used to confirm the increase in MMP-13 expression following glucocorticoid treatment and showed elevated MMP-13 expression in the rostral trunk, brain, eye, heart, and anterior kidney of treated embryos. These data demonstrate that normal zebra fish embryogenesis requires MMP-13 and that dexamethasone and hydrocortisone modulate the expression of this gene, leading to increased activity and potentially contributing to subsequent dysmorphogenesis.

[1]  J. Connell,et al.  Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to Patients with adrenal insufficiency , 2007, Clinical endocrinology.

[2]  S. Hahner,et al.  Pituitary-interrenal interaction in zebrafish interrenal organ development. , 2007, Molecular endocrinology.

[3]  P. Prunet,et al.  Multiple corticosteroid receptors in fish: from old ideas to new concepts. , 2006, General and comparative endocrinology.

[4]  J. D’Armiento,et al.  Matrix metalloproteinases in development and disease. , 2006, Birth defects research. Part C, Embryo today : reviews.

[5]  G. Lip,et al.  What role do extracellular matrix changes contribute to the cardiovascular disease burden of diabetes mellitus? , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[6]  D. Pilgrim,et al.  Ontogeny and regulation of matrix metalloproteinase activity in the zebrafish embryo by in vitro and in vivo zymography. , 2005, Developmental biology.

[7]  D. Buhler,et al.  Constitutive and xenobiotics-induced expression of a novel CYP3A gene from zebrafish larva. , 2005, Toxicology and applied pharmacology.

[8]  L. Jacobson,et al.  Hypothalamic-pituitary-adrenocortical axis regulation. , 2005, Endocrinology and metabolism clinics of North America.

[9]  Teresa Palomero,et al.  Suppression of apoptosis by bcl-2 overexpression in lymphoid cells of transgenic zebrafish. , 2005, Blood.

[10]  J. Rundhaug,et al.  Matrix metalloproteinases and angiogenesis , 2005, Journal of cellular and molecular medicine.

[11]  D. Edwards,et al.  Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption , 2005, Arthritis research & therapy.

[12]  Mahboob Rahman,et al.  Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. López-Otín,et al.  Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. , 2004, The International journal of developmental biology.

[14]  Hye-Seon Choi,et al.  Secretions of MMP‐9 by soluble glucocorticoid‐induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)δ and phospholipase D (PLD) in murine macrophage , 2004, Journal of cellular biochemistry.

[15]  W. Frederiks,et al.  Metabolic Mapping of Proteinase Activity with Emphasis on In Situ Zymography of Gelatinases , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[16]  S. Chakraborti,et al.  Regulation of matrix metalloproteinases: An overview , 2003, Molecular and Cellular Biochemistry.

[17]  Anna K. Greenwood,et al.  Multiple corticosteroid receptors in a teleost fish: distinct sequences, expression patterns, and transcriptional activities. , 2003, Endocrinology.

[18]  C. López-Otín,et al.  Loss of collagenase-2 confers increased skin tumor susceptibility to male mice , 2003, Nature Genetics.

[19]  V. Laudet,et al.  Evidence for two distinct functional glucocorticoid receptors in teleost fish. , 2003, Journal of molecular endocrinology.

[20]  M. Sarras,et al.  The expression of gelatinase A (MMP-2) is required for normal development of zebrafish embryos , 2003, Development Genes and Evolution.

[21]  M. Sarras,et al.  The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos , 2003, Development Genes and Evolution.

[22]  M. Sarras,et al.  The expression of novel membrane-type matrix metalloproteinase isoforms is required for normal development of zebrafish embryos. , 2003, Matrix biology : journal of the International Society for Matrix Biology.

[23]  M. Hendrix,et al.  Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells , 2003, Annals of the New York Academy of Sciences.

[24]  B. Kwon,et al.  Soluble glucocorticoid‐induced tumor necrosis factor receptor (sGITR) increased MMP‐9 activity in murine macrophage , 2003, Journal of cellular biochemistry.

[25]  J. Cidlowski,et al.  Molecular mechanisms of glucocorticoid action and resistance , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  E. Canalis,et al.  Mechanisms of Glucocorticoid Action in Bone , 2002, Current osteoporosis reports.

[27]  W. Almawi,et al.  Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids. , 2002, Journal of molecular endocrinology.

[28]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[29]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[30]  S. Curran,et al.  The Structure, Regulation, and Function of Human Matrix Metalloproteinase-13 , 2002, Critical reviews in biochemistry and molecular biology.

[31]  L. Kappos,et al.  Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis , 2001, Brain Research Reviews.

[32]  Marc Robinson-Rechavi,et al.  An ancestral whole-genome duplication may not have been responsible for the abundance of duplicated fish genes , 2001, Current Biology.

[33]  V. Laudet,et al.  Euteleost fish genomes are characterized by expansion of gene families. , 2001, Genome research.

[34]  P. Herrlich Cross-talk between glucocorticoid receptor and AP-1 , 2001, Oncogene.

[35]  V. Quesada,et al.  Identification and Enzymatic Characterization of Two Diverging Murine Counterparts of Human Interstitial Collagenase (MMP-1) Expressed at Sites of Embryo Implantation* , 2001, The Journal of Biological Chemistry.

[36]  S. Ekker,et al.  Effective targeted gene ‘knockdown’ in zebrafish , 2000, Nature Genetics.

[37]  V. Laudet,et al.  An inherited functional circadian clock in zebrafish embryos. , 2000, Science.

[38]  P. Billings,et al.  MMP‐13 is induced during chondrocyte hypertrophy , 2000, Journal of cellular biochemistry.

[39]  Bell Ce,et al.  Therapeutic issues in oral glucocorticoid use. , 1999 .

[40]  W. Bode,et al.  Structural properties of matrix metalloproteinases , 1999, Cellular and Molecular Life Sciences CMLS.

[41]  J. Campos-Ortega,et al.  A zebrafish Id homologue and its pattern of expression during embryogenesis , 1997, Mechanisms of Development.

[42]  C. López-Otín,et al.  Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[43]  H. Toyohara,et al.  Fish glucocorticoid receptor with splicing variants in the DNA binding domain , 1996, FEBS letters.

[44]  J. Delaissé,et al.  Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. , 1995, Journal of cell science.

[45]  C. Kimmel,et al.  Stages of embryonic development of the zebrafish , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[46]  E. Oxtoby,et al.  Cloning of the zebrafish krox-20 gene (krx-20) and its expression during hindbrain development. , 1993, Nucleic acids research.

[47]  F. Corpet Multiple sequence alignment with hierarchical clustering. , 1988, Nucleic acids research.

[48]  A. Ward,et al.  Characterization of the zebrafish matrix metalloproteinase 9 gene and its developmental expression pattern. , 2007, Gene expression patterns : GEP.

[49]  A. Poole,et al.  Cartilage matrix resorption in skeletogenesis. , 2001, Novartis Foundation symposium.

[50]  C. Brinckerhoff,et al.  Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. , 1996, Critical reviews in eukaryotic gene expression.

[51]  M. Westerfield The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio) , 1995 .

[52]  Alexander G. Weheliye,et al.  Smith ScholarWorks Smith ScholarWorks , 2022 .